This study compares the application of a picosecond 1064-nm laser with a diffractive lens array with nonablative fractional laser for the treatment of acne scarring.
This trial is a 17-week, prospective, randomized split-face study that compares the results between two facial sides either receiving the picosecond 1064-nm laser or nonablative fractional laser treatment for atrophic acne scar.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
25
4 consecutive sessions of laser therapy
Dongtan Sacred Heart Hospital, Hallym Universtiy College of Medicine
Hwaseong-si, Gyeonggi-do, South Korea
Changes in the mean of the ECCA grading scale
The ECCA (échelle d'évaluation clinique des cicatrices d'acné) grading scale: minimum score 0; maximum score 270; higher values represent a worse outcome.
Time frame: Week 17
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.